| Trial ID: | L2274 |
| Source ID: | NCT00225225
|
| Associated Drug: |
Rosiglitazone
|
| Title: |
Rosiglitazone-Induced Weight Gain
|
| Acronym: |
|
| Status: |
TERMINATED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Diabetes Mellitus, Type 2
|
| Interventions: |
DRUG: Rosiglitazone|BEHAVIORAL: dietary recommendation for weight maintenance
|
| Outcome Measures: |
Primary: modification of the diet prevents weight gain. | Secondary: develop specific dietary recommendations
|
| Sponsor/Collaborators: |
Sponsor: Stanford University | Collaborators: GlaxoSmithKline
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
|
| Enrollment: |
45
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: PREVENTION
|
| Start Date: |
2002-10
|
| Completion Date: |
2005-09
|
| Results First Posted: |
|
| Last Update Posted: |
2016-10-20
|
| Locations: |
Stanford University School of Medicine, Stanford, California, 94305, United States
|
| URL: |
https://clinicaltrials.gov/show/NCT00225225
|
